MetaImmune Inc.

📍 Belmont, United States🗓 Founded 2018👥 1 employees💰 Last funded Jun 2018
Biotechnology🌐 metaimmune.com
Website LinkedIn
MetaImmune is a biotechnology company on the quest to find curative therapies for cancer through targeting tumor-immune interactions. Through its rich portfolio and notable partnerships, MetaImmune is pioneering innovative research, leading to the next generation of revolutionary anticancer treatments, including small molecules, biologics and immunotherapies. For more information, please visit www.metaimmune.com, follow @MetaImmune on Twitter and LinkedIn.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in MetaImmune Inc.?
MetaImmune Inc. has 1 investor on record on gritt.io, including 1 early-stage backers.
When did MetaImmune Inc. last raise funding?
The most recent investment in MetaImmune Inc. recorded on gritt.io was in June 2018.
When was MetaImmune Inc. founded?
MetaImmune Inc. was founded in 2018.
What industry is MetaImmune Inc. in?
MetaImmune Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is MetaImmune Inc. based?
MetaImmune Inc. is headquartered in Belmont, United States.